Global Cytomegalovirus Treatment Market – Industry Analysis and Forecast (2020-2027) – by Drugs type, Application, Distribution channel and Region.

Global Cytomegalovirus Treatment Market – Industry Analysis and Forecast (2020-2027) – by Drugs type, Application, Distribution channel and Region.

Market Scenario

Global Cytomegalovirus Treatment Market was value US$ XXX Mn in 2019 and is expected to reach US$ XXX Mn by 2027 at a CAGR of XXX%. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding the global cytomegalovirus treatment market dynamics, structure by identifying and analysing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the global gram cytomegalovirus treatment market. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. Cytomegalovirus retinitis is a disease recognised by necrotizing retinitis that can begin to cause retinal organization and blindness. Cytomegalovirus retinitis and other exhibitions of cytomegalovirus disease in individuals with HIV-1 infection are opportunistic infections, transpiring when CD4+ cell counts are much suppressed. High value-added active antiretroviral therapy will drive the growth of the cytomegalovirus treatment market globally. The growing demand for cytomegalovirus treatment, owing to the increasing prevalence of cytomegalovirus retinitis in AIDS patients is the major factor fuelling the cytomegalovirus treatment market across the world. Other major factors driving the global cytomegalovirus treatment market are increasing the prevalence of cytomegalovirus retinitis cases and improvement in the healthcare facilities. Additionally, increasing government initiatives towards healthcare infrastructure in developing countries are also fuelling the growth of global cytomegalovirus treatment market. But, lack of awareness among people for different types of eye diseases and lack of healthcare insurance are some of the major factors restraining the global cytomegalovirus treatment market. Stem cell transplantation segment is leading the global cytomegalovirus treatment market. The increasing prevalence and incidences of cytomegalovirus infections is a prime driver of the cytomegalovirus treatment market globally. The cytomegalovirus treatment market is mainly grown as of the growing prevalence rate of cytomegalovirus infection in different indications such as congenital CMV, cytomegalovirus retinitis, stem cell transplant. The rising awareness of herpes is also driving the cytomegalovirus treatment market. Region-wise, North America is dominating the global cytomegalovirus treatment market followed by Europe were anticipated to contribute a major share in the cytomegalovirus infection treatment market owing to the high prevalence rate of cytomegalovirus infection. As per the Centre for Disease Control and Prevention (CDC), approximately, 80,000 cases of CMV infections were diagnosed in US and Europe. The Asia-Pacific is anticipated to grow rapidly owing to the large patient pool, and an increase in the prevalence of many infectious diseases as well as a rise in the awareness of cytomegalovirus infections.

Scope of the Global Cytomegalovirus Treatment Market

Global Cytomegalovirus Treatment Market, by Drugs Type

• Ganciclovir • Valganciclovir • Foscarnet • Cidofovir • Other

Global Cytomegalovirus Treatment Market, by Application

• Stem cell transplantation • Organ transplantation • Congenital CMV infection

Global Cytomegalovirus Treatment Market, by Distribution Channel

• Hospital pharmacies • Retail pharmacies • E-commerce.

Global Cytomegalovirus Treatment Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Key players operating in Global Cytomegalovirus Treatment Market

• Merck & Co. Inc • Mylan N.V. • Chimerix, Inc. • Thermo Fisher Scientific • Abbott • Becton • Dickinson and Company • Johnson & Johnson • Bio-Rad Laboratories, Inc. • F. Hoffmann-La Roche Ltd • Pfizer

Table of Contents

Global Cytomegalovirus Treatment Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Cytomegalovirus Treatment Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Cytomegalovirus Treatment Market Analysis and Forecast 6.1. Global Cytomegalovirus Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Cytomegalovirus Treatment Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Cytomegalovirus Treatment Market Value Share Analysis, by Application 7.4. Global Cytomegalovirus Treatment Market Size (US$ Mn) Forecast, by Application 7.5. Global Cytomegalovirus Treatment Market Analysis, by Application 7.6. Global Cytomegalovirus Treatment Market Attractiveness Analysis, by Application 8. Global Cytomegalovirus Treatment Market Analysis and Forecast, by Drugs type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Cytomegalovirus Treatment Market Value Share Analysis, by Drugs type 8.4. Global Cytomegalovirus Treatment Market Size (US$ Mn) Forecast, by Drugs type 8.5. Global Cytomegalovirus Treatment Market Analysis, by Drugs type 8.6. Global Cytomegalovirus Treatment Market Attractiveness Analysis, by Drugs type 9. Global Cytomegalovirus Treatment Market Analysis and Forecast, by Distribution channel 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Cytomegalovirus Treatment Market Value Share Analysis, by Distribution channel 9.4. Global Cytomegalovirus Treatment Market Size (US$ Mn) Forecast, by Distribution channel 9.5. Global Cytomegalovirus Treatment Market Analysis, by Distribution channel 9.6. Global Cytomegalovirus Treatment Market Attractiveness Analysis, by Distribution channel 10. Global Cytomegalovirus Treatment Market Analysis, by Region 10.1. Global Cytomegalovirus Treatment Market Value Share Analysis, by Region 10.2. Global Cytomegalovirus Treatment Market Size (US$ Mn) Forecast, by Region 10.3. Global Cytomegalovirus Treatment Market Attractiveness Analysis, by Region 11. North America Cytomegalovirus Treatment Market Analysis 11.1. Key Findings 11.2. North America Cytomegalovirus Treatment Market Overview 11.3. North America Cytomegalovirus Treatment Market Value Share Analysis, by Application 11.4. North America Cytomegalovirus Treatment Market Forecast, by Application 11.4.1. Stem cell transplantation 11.4.2. Organ transplantation 11.4.3. Congenital CMV infection 11.5. North America Cytomegalovirus Treatment Market Value Share Analysis, by Drugs type 11.6. North America Cytomegalovirus Treatment Market Forecast, by Drugs type 11.6.1. Ganciclovir 11.6.2. Valganciclovir 11.6.3. Foscarnet 11.6.4. Cidofovir 11.6.5. Other 11.7. North America Cytomegalovirus Treatment Market Value Share Analysis, by Distribution channel 11.8. North America Cytomegalovirus Treatment Market Forecast, by Distribution channel 11.8.1. Hospital pharmacies 11.8.2. Retail pharmacies 11.8.3. E-commerce 11.9. North America Cytomegalovirus Treatment Market Value Share Analysis, by Country 11.10. North America Cytomegalovirus Treatment Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Cytomegalovirus Treatment Market Analysis, by Country 11.12. U.S. Cytomegalovirus Treatment Market Forecast, by Application 11.12.1. Stem cell transplantation 11.12.2. Organ transplantation 11.12.3. Congenital CMV infection 11.13. U.S. Cytomegalovirus Treatment Market Forecast, by Drugs type 11.13.1. Ganciclovir 11.13.2. Valganciclovir 11.13.3. Foscarnet 11.13.4. Cidofovir 11.13.5. Other 11.14. U.S. Cytomegalovirus Treatment Market Forecast, by Distribution channel 11.14.1. Hospital pharmacies 11.14.2. Retail pharmacies 11.14.3. E-commerce 11.15. Canada Cytomegalovirus Treatment Market Forecast, by Application 11.15.1. Stem cell transplantation 11.15.2. Organ transplantation 11.15.3. Congenital CMV infection 11.16. Steel Canada Cytomegalovirus Treatment Market Forecast, by Drugs type 11.16.1. Ganciclovir 11.16.2. Valganciclovir 11.16.3. Foscarnet 11.16.4. Cidofovir 11.16.5. Other 11.17. Canada Cytomegalovirus Treatment Market Forecast, by Distribution channel 11.17.1. Hospital pharmacies 11.17.2. Retail pharmacies 11.17.3. E-commerce 11.18. North America Cytomegalovirus Treatment Market Attractiveness Analysis 11.18.1. By Application 11.18.2. By Drugs type 11.18.3. By Distribution channel 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Cytomegalovirus Treatment Market Analysis 12.1. Key Findings 12.2. Europe Cytomegalovirus Treatment Market Overview 12.3. Europe Cytomegalovirus Treatment Market Value Share Analysis, by Application 12.4. Europe Cytomegalovirus Treatment Market Forecast, by Application 12.4.1. Stem cell transplantation 12.4.2. Organ transplantation 12.4.3. Congenital CMV infection 12.5. Europe Cytomegalovirus Treatment Market Value Share Analysis, by Drugs type 12.6. Europe Cytomegalovirus Treatment Market Forecast, by Drugs type 12.6.1. Ganciclovir 12.6.2. Valganciclovir 12.6.3. Foscarnet 12.6.4. Cidofovir 12.6.5. Other 12.7. Europe Cytomegalovirus Treatment Market Value Share Analysis, by Distribution channel 12.8. Europe Cytomegalovirus Treatment Market Forecast, by Distribution channel 12.8.1. Hospital pharmacies 12.8.2. Retail pharmacies 12.8.3. E-commerce 12.9. Europe Cytomegalovirus Treatment Market Value Share Analysis, by Country 12.10. Europe Cytomegalovirus Treatment Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Cytomegalovirus Treatment Market Analysis, by Country 12.12. Germany Cytomegalovirus Treatment Market Forecast, by Application 12.12.1. Stem cell transplantation 12.12.2. Organ transplantation 12.12.3. Congenital CMV infection 12.13. Germany Cytomegalovirus Treatment Market Forecast, by Drugs type 12.13.1. Ganciclovir 12.13.2. Valganciclovir 12.13.3. Foscarnet 12.13.4. Cidofovir 12.13.5. Other 12.14. Germany Cytomegalovirus Treatment Market Forecast, by Distribution channel 12.14.1. Hospital pharmacies 12.14.2. Retail pharmacies 12.14.3. E-commerce 12.15. U.K. Cytomegalovirus Treatment Market Forecast, by Application 12.15.1. Stem cell transplantation 12.15.2. Organ transplantation 12.15.3. Congenital CMV infection 12.16. U.K. Cytomegalovirus Treatment Market Forecast, by Drugs type 12.16.1. Ganciclovir 12.16.2. Valganciclovir 12.16.3. Foscarnet 12.16.4. Cidofovir 12.16.5. Other 12.17. U.K. Cytomegalovirus Treatment Market Forecast, by Distribution channel 12.17.1. Hospital pharmacies 12.17.2. Retail pharmacies 12.17.3. E-commerce 12.18. France Cytomegalovirus Treatment Market Forecast, by Application 12.18.1. Stem cell transplantation 12.18.2. Organ transplantation 12.18.3. Congenital CMV infection 12.19. France Cytomegalovirus Treatment Market Forecast, by Drugs type 12.19.1. Ganciclovir 12.19.2. Valganciclovir 12.19.3. Foscarnet 12.19.4. Cidofovir 12.19.5. Other 12.20. France Cytomegalovirus Treatment Market Forecast, by Distribution channel 12.20.1. Hospital pharmacies 12.20.2. Retail pharmacies 12.20.3. E-commerce 12.21. Italy Cytomegalovirus Treatment Market Forecast, by Application 12.21.1. Stem cell transplantation 12.21.2. Organ transplantation 12.21.3. Congenital CMV infection 12.22. Italy Cytomegalovirus Treatment Market Forecast, by Drugs type 12.22.1. Ganciclovir 12.22.2. Valganciclovir 12.22.3. Foscarnet 12.22.4. Cidofovir 12.22.5. Other 12.23. Italy Cytomegalovirus Treatment Market Forecast, by Distribution channel 12.23.1. Hospital pharmacies 12.23.2. Retail pharmacies 12.23.3. E-commerce 12.24. Spain Cytomegalovirus Treatment Market Forecast, by Application 12.24.1. Stem cell transplantation 12.24.2. Organ transplantation 12.24.3. Congenital CMV infection 12.25. Spain Cytomegalovirus Treatment Market Forecast, by Drugs type 12.25.1. Ganciclovir 12.25.2. Valganciclovir 12.25.3. Foscarnet 12.25.4. Cidofovir 12.25.5. Other 12.26. Spain Cytomegalovirus Treatment Market Forecast, by Distribution channel 12.26.1. Hospital pharmacies 12.26.2. Retail pharmacies 12.26.3. E-commerce 12.27. Rest of Europe Cytomegalovirus Treatment Market Forecast, by Application 12.27.1. Stem cell transplantation 12.27.2. Organ transplantation 12.27.3. Congenital CMV infection 12.28. Rest of Europe Cytomegalovirus Treatment Market Forecast, by Drugs type 12.28.1. Ganciclovir 12.28.2. Valganciclovir 12.28.3. Foscarnet 12.28.4. Cidofovir 12.28.5. Other 12.29. Rest Of Europe Cytomegalovirus Treatment Market Forecast, by Distribution channel 12.29.1. Hospital pharmacies 12.29.2. Retail pharmacies 12.29.3. E-commerce 12.30. Europe Cytomegalovirus Treatment Market Attractiveness Analysis 12.30.1. By Application 12.30.2. By Drugs type 12.30.3. By Distribution channel 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Cytomegalovirus Treatment Market Analysis 13.1. Key Findings 13.2. Asia Pacific Cytomegalovirus Treatment Market Overview 13.3. Asia Pacific Cytomegalovirus Treatment Market Value Share Analysis, by Application 13.4. Asia Pacific Cytomegalovirus Treatment Market Forecast, by Application 13.4.1. Stem cell transplantation 13.4.2. Organ transplantation 13.4.3. Congenital CMV infection 13.5. Asia Pacific Cytomegalovirus Treatment Market Value Share Analysis, by Drugs type 13.6. Asia Pacific Cytomegalovirus Treatment Market Forecast, by Drugs type 13.6.1. Ganciclovir 13.6.2. Valganciclovir 13.6.3. Foscarnet 13.6.4. Cidofovir 13.6.5. Other 13.7. Asia Pacific Cytomegalovirus Treatment Market Value Share Analysis, by Distribution channel 13.8. Asia Pacific Cytomegalovirus Treatment Market Forecast, by Distribution channel 13.8.1. Hospital pharmacies 13.8.2. Retail pharmacies 13.8.3. E-commerce 13.9. Asia Pacific Cytomegalovirus Treatment Market Value Share Analysis, by Country 13.10. Asia Pacific Cytomegalovirus Treatment Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Cytomegalovirus Treatment Market Analysis, by Country 13.12. China Cytomegalovirus Treatment Market Forecast, by Application 13.12.1. Stem cell transplantation 13.12.2. Organ transplantation 13.12.3. Congenital CMV infection 13.13. China Cytomegalovirus Treatment Market Forecast, by Drugs type 13.13.1. Ganciclovir 13.13.2. Valganciclovir 13.13.3. Foscarnet 13.13.4. Cidofovir 13.13.5. Other 13.14. China Cytomegalovirus Treatment Market Forecast, by Distribution channel 13.14.1. Hospital pharmacies 13.14.2. Retail pharmacies 13.14.3. E-commerce 13.15. India Cytomegalovirus Treatment Market Forecast, by Application 13.15.1. Stem cell transplantation 13.15.2. Organ transplantation 13.15.3. Congenital CMV infection 13.16. India Cytomegalovirus Treatment Market Forecast, by Drugs type 13.16.1. Ganciclovir 13.16.2. Valganciclovir 13.16.3. Foscarnet 13.16.4. Cidofovir 13.16.5. Other 13.17. India Cytomegalovirus Treatment Market Forecast, by Distribution channel 13.17.1. Hospital pharmacies 13.17.2. Retail pharmacies 13.17.3. E-commerce 13.18. Japan Cytomegalovirus Treatment Market Forecast, by Application 13.18.1. Stem cell transplantation 13.18.2. Organ transplantation 13.18.3. Congenital CMV infection 13.19. Japan Cytomegalovirus Treatment Market Forecast, by Drugs type 13.19.1. Ganciclovir 13.19.2. Valganciclovir 13.19.3. Foscarnet 13.19.4. Cidofovir 13.19.5. Other 13.20. Japan Cytomegalovirus Treatment Market Forecast, by Distribution channel 13.20.1. Hospital pharmacies 13.20.2. Retail pharmacies 13.20.3. E-commerce 13.21. ASEAN Cytomegalovirus Treatment Market Forecast, by Application 13.21.1. Stem cell transplantation 13.21.2. Organ transplantation 13.21.3. Congenital CMV infection 13.22. ASEAN Cytomegalovirus Treatment Market Forecast, by Drugs type 13.22.1. Ganciclovir 13.22.2. Valganciclovir 13.22.3. Foscarnet 13.22.4. Cidofovir 13.22.5. Other 13.23. ASEAN Cytomegalovirus Treatment Market Forecast, by Distribution channel 13.23.1. Hospital pharmacies 13.23.2. Retail pharmacies 13.23.3. E-commerce 13.24. Rest of Asia Pacific Cytomegalovirus Treatment Market Forecast, by Application 13.24.1. Stem cell transplantation 13.24.2. Organ transplantation 13.24.3. Congenital CMV infection 13.25. Rest of Asia Pacific Cytomegalovirus Treatment Market Forecast, by Drugs type 13.25.1. Ganciclovir 13.25.2. Valganciclovir 13.25.3. Foscarnet 13.25.4. Cidofovir 13.25.5. Other 13.26. Rest of Asia Pacific Cytomegalovirus Treatment Market Forecast, by Distribution channel 13.26.1. Hospital pharmacies 13.26.2. Retail pharmacies 13.26.3. E-commerce 13.27. Asia Pacific Cytomegalovirus Treatment Market Attractiveness Analysis 13.27.1. By Application 13.27.2. By Drugs type 13.27.3. By Distribution channel 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Cytomegalovirus Treatment Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Cytomegalovirus Treatment Market Overview 14.3. Middle East & Africa Cytomegalovirus Treatment Market Value Share Analysis, by Application 14.4. Middle East & Africa Cytomegalovirus Treatment Market Forecast, by Application 14.4.1. Stem cell transplantation 14.4.2. Organ transplantation 14.4.3. Congenital CMV infection 14.5. Middle East & Africa Cytomegalovirus Treatment Market Value Share Analysis, by Drugs type 14.6. Middle East & Africa Cytomegalovirus Treatment Market Forecast, by Drugs type 14.6.1. Ganciclovir 14.6.2. Valganciclovir 14.6.3. Foscarnet 14.6.4. Cidofovir 14.6.5. Other 14.7. Middle East & Africa Cytomegalovirus Treatment Market Value Share Analysis, by Distribution channel 14.8. Middle East & Africa Cytomegalovirus Treatment Market Forecast, by Distribution channel 14.8.1. Hospital pharmacies 14.8.2. Retail pharmacies 14.8.3. E-commerce 14.9. Middle East & Africa Cytomegalovirus Treatment Market Value Share Analysis, by Country 14.10. Middle East & Africa Cytomegalovirus Treatment Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Cytomegalovirus Treatment Market Analysis, by Country 14.12. GCC Cytomegalovirus Treatment Market Forecast, by Application 14.12.1. Stem cell transplantation 14.12.2. Organ transplantation 14.12.3. Congenital CMV infection 14.13. GCC Cytomegalovirus Treatment Market Forecast, by Drugs type 14.13.1. Ganciclovir 14.13.2. Valganciclovir 14.13.3. Foscarnet 14.13.4. Cidofovir 14.13.5. Other 14.14. GCC Cytomegalovirus Treatment Market Forecast, by Distribution channel 14.14.1. Hospital pharmacies 14.14.2. Retail pharmacies 14.14.3. E-commerce 14.15. South Africa Cytomegalovirus Treatment Market Forecast, by Application 14.15.1. Stem cell transplantation 14.15.2. Organ transplantation 14.15.3. Congenital CMV infection 14.16. South Africa Cytomegalovirus Treatment Market Forecast, by Drugs type 14.16.1. Ganciclovir 14.16.2. Valganciclovir 14.16.3. Foscarnet 14.16.4. Cidofovir 14.16.5. Other 14.17. South Africa Cytomegalovirus Treatment Market Forecast, by Distribution channel 14.17.1. Hospital pharmacies 14.17.2. Retail pharmacies 14.17.3. E-commerce 14.18. Rest of Middle East & Africa Cytomegalovirus Treatment Market Forecast, by Application 14.18.1. Stem cell transplantation 14.18.2. Organ transplantation 14.18.3. Congenital CMV infection 14.19. Rest of Middle East & Africa Cytomegalovirus Treatment Market Forecast, by Drugs type 14.19.1. Ganciclovir 14.19.2. Valganciclovir 14.19.3. Foscarnet 14.19.4. Cidofovir 14.19.5. Other 14.20. Rest of Middle East & Africa Cytomegalovirus Treatment Market Forecast, by Distribution channel 14.20.1. Hospital pharmacies 14.20.2. Retail pharmacies 14.20.3. E-commerce 14.21. Middle East & Africa Cytomegalovirus Treatment Market Attractiveness Analysis 14.21.1. By Application 14.21.2. By Drugs type 14.21.3. By Distribution channel 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Cytomegalovirus Treatment Market Analysis 15.1. Key Findings 15.2. South America Cytomegalovirus Treatment Market Overview 15.3. South America Cytomegalovirus Treatment Market Value Share Analysis, by Application 15.4. South America Cytomegalovirus Treatment Market Forecast, by Application 15.4.1. Stem cell transplantation 15.4.2. Organ transplantation 15.4.3. Congenital CMV infection 15.5. South America Cytomegalovirus Treatment Market Value Share Analysis, by Drugs type 15.6. South America Cytomegalovirus Treatment Market Forecast, by Drugs type 15.6.1. Ganciclovir 15.6.2. Valganciclovir 15.6.3. Foscarnet 15.6.4. Cidofovir 15.6.5. Other 15.7. South America Cytomegalovirus Treatment Market Value Share Analysis, by Distribution channel 15.8. South America Cytomegalovirus Treatment Market Forecast, by Distribution channel 15.8.1. Hospital pharmacies 15.8.2. Retail pharmacies 15.8.3. E-commerce 15.9. South America Cytomegalovirus Treatment Market Value Share Analysis, by Country 15.10. South America Cytomegalovirus Treatment Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Cytomegalovirus Treatment Market Analysis, by Country 15.12. Brazil Cytomegalovirus Treatment Market Forecast, by Application 15.12.1. Stem cell transplantation 15.12.2. Organ transplantation 15.12.3. Congenital CMV infection 15.13. Brazil Cytomegalovirus Treatment Market Forecast, by Drugs type 15.13.1. Ganciclovir 15.13.2. Valganciclovir 15.13.3. Foscarnet 15.13.4. Cidofovir 15.13.5. Other 15.14. Brazil Cytomegalovirus Treatment Market Forecast, by Distribution channel 15.14.1. Hospital pharmacies 15.14.2. Retail pharmacies 15.14.3. E-commerce 15.15. Mexico Cytomegalovirus Treatment Market Forecast, by Application 15.15.1. Stem cell transplantation 15.15.2. Organ transplantation 15.15.3. Congenital CMV infection 15.16. Mexico Cytomegalovirus Treatment Market Forecast, by Drugs type 15.16.1. Ganciclovir 15.16.2. Valganciclovir 15.16.3. Foscarnet 15.16.4. Cidofovir 15.16.5. Other 15.17. Mexico Cytomegalovirus Treatment Market Forecast, by Distribution channel 15.17.1. Hospital pharmacies 15.17.2. Retail pharmacies 15.17.3. E-commerce 15.18. Rest of South America Cytomegalovirus Treatment Market Forecast, by Application 15.18.1. Stem cell transplantation 15.18.2. Organ transplantation 15.18.3. Congenital CMV infection 15.19. Rest of South America Cytomegalovirus Treatment Market Forecast, by Drugs type 15.19.1. Ganciclovir 15.19.2. Valganciclovir 15.19.3. Foscarnet 15.19.4. Cidofovir 15.19.5. Other 15.20. Rest of South America Cytomegalovirus Treatment Market Forecast, by Distribution channel 15.20.1. Hospital pharmacies 15.20.2. Retail pharmacies 15.20.3. E-commerce 15.21. South America Cytomegalovirus Treatment Market Attractiveness Analysis 15.21.1. By Application 15.21.2. By Drugs type 15.21.3. By Distribution channel 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Merck & Co. Inc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Developing Footprint 16.3.2. Mylan N.V. 16.3.3. Chimerix, Inc. 16.3.4. Thermo Fisher Scientific 16.3.5. Abbott 16.3.6. Becton 16.3.7. Dickinson and Company 16.3.8. Johnson & Johnson 16.3.9. Bio-Rad Laboratories, Inc. 16.3.10. F. Hoffmann-La Roche Ltd 16.3.11. Pfizer 17. Primary Key Insights

About This Report

Report ID25371
Category Healthcare
Published DateJAN 2020
No of Pages184
Contact Us
Call Now